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Visual Abstract
Significance Statement
Alterations in brain serotonin (5-HT) levels during development can interfere with neuronal circuitry estab-
lishment and contribute to behavioral disturbances in adult life. It remains enigmatic whether wiring patterns
can be reshaped by fluctuations of 5-HT content in the adult brain. In this study, we show for the first time
that the adult serotonergic circuitry is susceptible to perturbations of serotonin homeostasis. These results
provide evidence of life-long requirement of proper 5-HT levels to preserve the serotonergic axonal wiring.
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Growing evidence shows that the neurotransmitter serotonin (5-HT) modulates the fine-tuning of neuron devel-
opment and the establishment of wiring patterns in the brain. However, whether serotonin is involved in the
maintenance of neuronal circuitry in the adult brain remains elusive. Here, we use a Tph2fl°x conditional knockout
(cKO) mouse line to assess the impact of serotonin depletion during adulthood on serotonergic system organi-
zation. Data show that the density of serotonergic fibers is increased in the hippocampus and decreased in the
thalamic paraventricular nucleus (PVN) as a consequence of brain serotonin depletion. Strikingly, these defects
are rescued following reestablishment of brain 5-HT signaling via administration of the serotonin precursor
5-hydroxytryptophan (5-HTP). Finally, 3D reconstruction of serotonergic fibers reveals that changes in serotonin
homeostasis affect axonal branching complexity. These data demonstrate that maintaining proper serotonin
homeostasis in the adult brain is crucial to preserve the correct serotonergic axonal wiring.
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Introduction
Serotonin (5-hydroxytryptamnine, 5-HT) is a monoam-
inergic neuromodulator that orchestrates a broad array
of processes from autonomic, cognitive and behavioral
functions to the modulation of specific morphogenetic
events during neurodevelopment (Gaspar et al., 2003;
Ruhé et al., 2007; Alenina et al., 2009; Daubert and Con-
dron 2010; Asan et al., 2013; Migliarini et al., 2013; Suri
et al., 2015).
Neurons that synthetize serotonin are specified early
during embryogenesis in the mouse hindbrain, where they
cluster to form B1 to B9 raphe nuclei. Despite the fact that
serotonergic neurons are relatively few in number (25,000
in mice; Ishimura et al., 1988), long-range projections and
highly collateralized axons allow them to establish diffuse
axonal trajectories to innervate the whole CNS (Gagnon
and Parent 2014). By the end of gestation, serotonergic
axon terminals have reached all the brain regions that will
receive serotonergic innervation, and during the first three
postnatal weeks, they actively sprout to profusely inner-
vate their targets (Lidov and Molliver, 1982; Wallace and
Lauder, 1983).
Maternal and placental sources of serotonin are essen-
tial for the development of the fetus (Côté et al., 2007;
Bonnin et al., 2011; Goeden et al., 2016). This evidence,
along with the early presence of serotonergic receptors in
the developing brain, suggests that 5-HT plays a role in
the orchestration of specific neurodevelopmental events
(Lauder, 1993; Gaspar et al., 2003). Indeed, it has been
extensively reported that an appropriate serotonergic
neurotransmission is essential for the correct develop-
ment of the CNS. Examples emerged from studies on
animal models in which a perturbation of 5-HT homeosta-
sis was obtained by inactivating genes coding for the
serotonin transporter (SERT) or for the monoamine oxi-
dase A. In these mice, an excess of brain serotonin during
early development resulted in the disruption of topo-
graphically organized whisker-barrel fields in the somato-
sensory cortex (Cases et al., 1996; Persico et al., 2001)
and in an abnormal migration of cortical neurons (Riccio
et al., 2009; Murthy et al., 2014). Interesting insights into
the role of serotonin during neurodevelopment derived
also from the generation of tryptophan hydroxylase 2
knockout (Tph2 KO) mice, in which the rate-limiting en-
zyme for serotonin biosynthesis in the CNS was inacti-
vated (Savelieva et al., 2008; Alenina et al., 2009;
Gutknecht et al., 2012; Migliarini et al., 2013). Although
these mice failed to show gross brain malformations, a
broad number of alterations was identified, suggesting
that serotonergic signaling is essential for the fine-tuning
modulation of neurodevelopmental events. Indeed, Tph2
KO mice showed physiologic modifications, altered be-
havior, impaired adult neurogenesis in response to run-
ning, and severe alterations in serotonergic circuitry
development (Klempin et al., 2013; Migliarini et al., 2013;
Mosienko et al., 2015).
Regarding the latter aspect, an important question that
remains to be addressed is whether serotonin, besides its
trophic role during development, is also required in the
adult brain for the maintenance of serotonergic circuitry.
Here, we used a Tph2fl°x conditional KO (cKO) mouse line
to test whether severe unbalances in brain 5-HT neurotrans-
mission during adulthood could affect the organization of
serotonergic circuitry. We show that the disruption of 5-HT
synthesis in adult mice deeply affects serotonergic in-
nervation of rostral brain targets with a region-specific
effect, and that a close-to-normal innervation pattern is
reestablished when brain serotonin signaling is restored
Received December 19, 2016; accepted February 17, 2017; First published
April 3, 2017.
The authors declare no competing financial interests.
Author contributions: M.Pr., S.M., B.P., and M.Pa. designed research; M.Pr.,
S.M., B.P., F.N., A.U., and M.Pa. performed research; M.Pr., S.M., F.N., A.U.,
and M.Pa. analyzed data; M.Pr., B.P., and M.Pa. wrote the paper.
This work was supported by Italian Ministry of Education, University and
Research (MIUR) (Prin 2008, 200894SYW2), Toscana Life Sciences Founda-
tion (Orphan_0108 program), and Norwegian Research Council (to M.Pa.). B.P.
and M.Pr. were supported by the PhD Program from University of Pisa. S.M.
was supported by the Regional Program and European Social Fund.
Barbara Pelosi’s present address: Laboratory of Neural Differentiation, In-
stitute of Neuroscience, UCL, Brussels, 1200, Belgium.
Acknowledgments: We thank C. Valente for excellent technical assistance
and members of our laboratory for valuable discussions and comments on the
manuscript. We also thank Dr. P. Chambon and Dr. D. Metzger for the
CMV-CreERT mouse line.
Correspondence should be addressed to Massimo Pasqualetti, University of
Pisa, Department of Biology, Unit of Cell and Developmental Biology, Strada
statale 12 Abetone e Brennero, Pisa 56127, Italy. E-mail: massimo.pasqualetti@
unipi.it.
DOI:http://dx.doi.org/10.1523/ENEURO.0376-16.2017
Copyright © 2017 Pratelli et al.
This is an open-access article distributed under the terms of the Creative
Commons Attribution 4.0 International license, which permits unrestricted use,
distribution and reproduction in any medium provided that the original work is
properly attributed.
New Research 2 of 13
March/April 2017, 4(2) e0376-16.2017 eNeuro.org
by chronic administration of the serotonin precursor
5-hydroxytryptophan (5-HTP). On the whole, these re-
sults prove that an appropriate serotonin homeostasis is
crucial for the maintenance of serotonergic circuitry dur-
ing adult stages of life.
Materials and Methods
Animals
Animals were maintained on artificial 12/12 h light/dark
cycle at constant temperature of 22  1°C and were
housed in standard Plexiglas cages with food and water
ad libitum. All experimental protocols were conducted in
accordance with the Ethic Committee of the University of
Pisa and approved by the Veterinary Department of the
Italian Ministry of Health.
To allow detection of serotonergic fibers independently
of 5-HT immunoreactivity and to abrogate serotonin synthe-
sis in a time-controlled manner, Tph2GFP/fl°x::CMVCreERT
mice were generated (Feil et al., 1996, RRID: MGI_2387570;
Migliarini et al., 2013, RRID: MGI_5442773; Pelosi et al.,
2015, RRID: MGI_5823194). Animals were on C57BL/6
background obtained by backcrossing with C57BL/6 mice
for at least nine generations.
All animals used in the experiments were males. Mice
from the same litter were treated with either drugs or
vehicle/saline and samples were processed in parallel to
minimize treatment-independent variability.
Pharmacological treatments
Tph2GFP/fl°x::CMVCreERT mice were injected intraperi-
toneally once a day starting at postnatal day 60 (P60) for
five consecutive days with 75 mg/kg body weight tamox-
ifen (TM, Sigma-Aldrich) dissolved in sunflower oil/ethanol
(1:9) as previously described (Pelosi et al., 2015). In par-
allel, littermates of the same genotype were injected with
sunflower oil/ethanol (1:9; vehicle) and were used as con-
trols.
Mice were chronically administered with 5-HTP for 30
consecutive days starting form three months of age for
Tph2GFP mutant mice, and 30 days after the last TM-
injection for TM-treated Tph2GFP/fl°x::CMVCreERT mice. For
chronic 5-HTP treatment, mice were intraperitoneally in-
jected twice a day (9 A.M. to 7 P.M.) with 5-HTP (Sigma-
Aldrich; 20 mg/kg) dissolved in sodium chloride 0.9%
(saline) for 30 consecutive days. In parallel, to prevent an
excessive decline in 5-HT concentration few hours after
intraperitoneal injections (Mosienko et al., 2015), animals
received a supplementation of 5-HTP dissolved in drink-
ing water. 5-HTP concentration in drinking water was
calculated to reach the final dose of 300 mg/kg/d, taking
into account the weight of the animal and the average
amount of water consumed daily. Control animals of the
same litter were injected with saline and received water
not supplemented with 5-HTP.
Immunohistochemistry and in situ hybridization (ISH)
Immunohistochemistry and ISH were performed follow-
ing standard protocols (Pelosi et al., 2014). Briefly, for
immunohistochemistry, animals were deeply anesthetized
with intraperitoneal injection of Avertin (1.25% solution of
2, 2, 2-tribromoethanol, Sigma-Aldrich) at 0.02 ml/g body
weight and perfused transcardially with PBS followed by
4% paraformaldehyde (PFA). Brains were dissected out
and postfixed overnight (o/n) at 4°C in 4% PFA before
being sectioned with a vibratome (Leica Microsystem) to
obtain 50-m-thick coronal sections. Free-floating sec-
tions were cryoprotected and a one-in-three series of
sections for each brain was incubated with primary anti-
body.
To detect 5-HT and GFP colocalization in serotonergic
neurons and fibers, sections were incubated o/n at 4°C
with a solution of rabbit anti-5-HT (1:500, Sigma-Aldrich,
RRID: AB_477522) and chicken anti-GFP (1:1000, Abcam,
RRID: AB_300798) primary antibodies in PBS containing
5% heat-inactivated lamb serum and 0.5% Triton X-100.
Section were then incubated o/n in the same solution
containing Rhodamine Red-X goat anti-rabbit IgG 1:500
(Thermo Fisher Scientific, RRID: AB_10374436) and Alexa
Fluor 488 goat anti-chicken IgG 1:200 (Thermo Fisher
Scientific, RRID: AB_2534096) secondary antibodies. For
the analysis of serotonergic fibers, brain sections were
immunostained for GFP using a rabbit anti-GFP primary
antibody (1:2000, Invitrogen, RRID: AB_221570). To avoid
the interference of endogenous GFP fluorescence in the
relative optical density (ROD) quantification, a Rhodamine
Red-X-conjugated goat anti-rabbit IgG antibody was used (1:
500, Thermo Fisher Scientific, RRID: AB_10374436). To deter-
mine background fluorescence adjacent sections were
processed omitting the primary antibody. Cell nuclei were
counterstained with DAPI 0.5 mg/ml (Sigma-Aldrich).
For SERT labeling, sections were first incubated for 30
min in 0.05% hydrogen peroxide in PBS and 0.03% Triton
X-100 to block endogenous peroxidase activity, and sub-
sequently incubated for 36 h with a rabbit anti-SERT
antibody (1:500, Millipore, RRID: AB_612176) in PBS con-
taining 10% heat-inactivated lamb serum and 0.3% Triton
X-100. To achieve signal amplification the avidin-biotin-
HRP conjugate solution (VECTASTAIN Elite ABC kit, Vec-
tor Labs, RRID: AB_2336810) was used, following the
manufacturer’s instructions. Staining was obtained by a
10-min incubation with 3-30 diaminobenzidine tetrahy-
drochloride (Sigma-Aldrich). For ISH, brains were dis-
sected out, embedded in TISSUE Tek (Sakura), frozen on
dry ice, and stored at -80°C. Coronal 14-m-thick sec-
tions were cut using a cryostat and ISH was performed
accordingly to standardized protocols using a 35S-labeled
BDNF antisense RNA probe previously described (Migli-
arini et al., 2013). Sections were then exposed to Biomax
MR x-ray films (Kodak) for 2 d.
Western blot analysis
For Western blot analysis, mice were killed by decapi-
tation, and the hippocampus was dissected out, frozen in
liquid nitrogen, and stored at 80°C. Hippocampal sam-
ples were sonicated in a lysis buffer (320 mM sucrose, 50
mM Tris HCl, pH 7.5, 50 mM NaCl, 1% Triton X-100, 5
mM -glycerol phosphate, 1 mM Na3VO4, 5 mM NaF,
protease inhibitor cocktail) and, after a 30-min incubation
in ice and 10-min spinning at 12,000  g, the supernatant
was collected. After protein determination by Bio-Rad
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Protein Assay kit (Bio-Rad), equal amounts of total pro-
teins (30 g) for each hippocampal sample were loaded
onto both 10% and 15% polyacrylamide gels to deter-
mine BDNF and tyrosine receptor kinase B (TrkB) levels,
respectively. Proteins were separated by SDS-PAGE and
transferred overnight to membranes (Immobilon PVDF
Membrane, Millipore). Then, membranes were immuno-
blotted overnight using selective antibodies against BDNF
(1:500, Santa Cruz Biotechnology, RRID: AB_630940)
and TrkB (1:1000, Santa Cruz Biotechnology, RRID:
AB_2155274). Blots were then incubated with appropri-
ate HRP-conjugated secondary antibody and target pro-
teins were visualized by ECL detection (GE Health Care),
followed by quantification through Quantity One software
(Bio-Rad, RRID: SCR_014280). All optical density values
of BDNF and TrkB were normalized using an antibody
against GAPDH (1:5000, Santa Cruz Biotechnology, RRID:
AB_627679) and -tubulin (1:50,000, Sigma-Aldrich, RRID:
AB_477593), respectively.
Images analysis and quantification
Analysis of serotonergic fiber density was conducted
on coronal brain sections immunostained for GFP. All the
pictures were randomized before signal quantification,
and the operator who performed the analysis was blinded
to genotype and treatment.
The density of serotonergic fibers was manually quan-
tified by ROD measurements following the procedure pre-
viously described by Migliarini et al. (2013). Images were
taken with Eclipse Ti microscope (Nikon) using 10 or 4
objectives depending on the brain structure under analy-
sis and constant acquisition parameters, and using both
rhodamine and DAPI filter. Images were then converted to
gray-scale (8-bit) and the optical density (OD) was quan-
tified within the area of interest in both hippocampus and
thalamic paraventricular nucleus (PVN) taking advantage
of the DAPI staining using ImageJ software (RRID:
SCR_003070). To calculate ROD values, the background
fluorescence was subtracted from the measured OD.
Background fluorescence was assessed by measuring
the OD on control adjacent sections processed omitting
the primary antibody.
To measure the intensity of GFP immunosignal within
serotonergic neurons, images were acquired with a
Nikon-A1 confocal microscope using a 10 objective and
constant acquisition parameters. Images were composed
of 17 z-stacks obtained at 0.3-m step size (voxel size of
1.24, 1.24, and 1 m/pixel in x-, y-, and z-dimensions,
respectively). For each animal, three representative im-
ages of the median and dorsal raphe nuclei were acquired
and the intensity of GFP fluorescence within 5-HT neu-
rons was measured using the Surface tool of the Imaris
Bitplane software (version 7.2.3, RRID: SCR_007370).
For the quantification of BDNF mRNA expression in the
hippocampus, autoradiography films resulting from radio-
active ISH were scanned at a resolution of 3200 dpi. The
OD values were evaluated using the ImageJ software in
the pyramidal cell layer of Ammon’s horn (CA) and in the
granule cell layer of the dentate gyrus (DG) of the hip-
pocampus. To obtain the ROD value, for each analyzed
section the background OD was determined in structures
of the same section devoid of signal. At least five sections
for each animal were quantified.
For 3D morphologic analysis of serotonergic fibers,
high-magnification confocal images were acquired using
a Nikon-A1 confocal microscope. Acquisitions were per-
formed using a 60 objective at a digital zoom of 3.0 and
were composed of 60 z-stacks obtained at 0.3 m step
size (voxel size of 0.07, 0.07, and 0,3 m/pixel in x-, y-,
and z-dimensions, respectively). For each animal, three
consecutive sections from a one-in-three series along the
antero-posterior axis were analyzed performing the acqui-
sitions at the level of the stratum lacunosum moleculare
using the same dorso-ventral and lateral coordinates.
Accordingly to the procedure described by Scott et al.
(2013), the semiautomatic fiber tracking software Imaris
Bitplane (version 7.2.3, RRID: SCR_007366) was used to
generate a 3D map of serotonin axons. Computer-based
quantifications of morphologic parameters such as axon
length (AL), axon mean diameter, number of axon branch
points and tortuosity index were automatically performed
by Imaris software on the reconstructed fibers.
Statistical analysis
Tests of significance for two-sample comparisons were
performed using two-tailed Wilcoxon singed rank exact
test for paired data or two-tailed Student’s t test. For
three-sample comparison, we used Friedman test fol-
lowed by two-tailed Wilcoxon signed rank exact test. For
3D reconstruction of GFP-positive fibers, Friedman test
followed by one-tailed Wilcoxon signed rank exact test
was used. Bonferroni’s correction was applied in case of
multiple comparisons; p  0.05 was considered statisti-
cally significant.
Results
Depletion of serotonin in the adult brain results in
the alteration of serotonergic innervation density
To address the consequences of serotonin depletion in
adulthood, we took advantage of the combination of two
mouse lines. We used the Tph2fl°x inducible KO allele, in
which Tph2 exon 3 has been floxed allowing the abroga-
tion of serotonin synthesis on time-specific Cre recombi-
nase activity following TM administration (Pelosi et al.,
2015). We also took advantage of the Tph2::eGFP
knockin mouse line (defined Tph2GFP from now on), in
which the substitution of the Tph2 gene with the GFP
cDNA results in both the disruption of Tph2 expression
and the expression of the fluorescent reporter mirroring
the presence of serotonin in both somata and projections
of serotonergic neurons in developing and adult animals
(Migliarini et al., 2013). By intercrossing the two lines, we
obtained Tph2GFP/fl°x trans-heterozygous mice, harboring
an inactive Tph2GFP knockin allele and a Tph2fl°x allele
that can be inactivated on Cre-mediated somatic recom-
bination. Tph2GFP/fl°x trans-heterozygous mice were born
at normal Mendelian ratios and lived a normal lifespan
without showing any obvious defect. To conditionally ab-
late serotonin synthesis in adult animals, we then inter-
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crossed Tph2GFP/fl°x mice to the CMVCreERT mouse line
to obtain Tph2GFP/fl°x::CMVCreERT mice, in which Cre
recombinase transcription is driven by a cytomegalovirus
promoter and its site-specific DNA recombination activity
is conditionally activated on administration of TM (Feil
et al., 1996). Adult Tph2GFP/fl°x::CMVCreERT animals were
treated at P60 with TM once a day for five consecutive
days to deplete serotonin synthesis as previously de-
scribed (Pelosi et al., 2015). TM-treated Tph2GFP/fl°x::
CMVCreERT mice, analyzed one week after the end of TM
treatment, showed an almost complete loss of serotonin
immunoreactivity in the raphe nuclei as previously shown
(Pelosi et al., 2015) as well as in serotonergic terminals
reaching the rostral brain, as compared with vehicle-
treated control mice (Fig. 1A,B).
As lack of central serotonin in Tph2GFP mutants has
been shown to affect serotonergic fiber sprouting in the
hippocampus, the nucleus accumbens, the suprachias-
matic nucleus, and the thalamic PVN with a region-
specific effect (Migliarini et al., 2013), we asked whether
the conditional removal of this monoamine in adulthood
could result in similar alterations. We thus compared the
organization of GFP-positive serotonergic fibers in TM-
versus vehicle-treated Tph2GFP/fl°x::CMVCreERT animals,
14, 30, or 60 days after the last TM injection (D14, D30,
and D60, respectively; Fig. 1C), and we focused our anal-
ysis on two brain regions such as the hippocampus and
the thalamic PVN that showed pronounced and opposite
alterations in Tph2GFP mutant mice (Migliarini et al., 2013).
Analysis of ROD at D14 showed no significant changes in
serotonin innervation between the two treatment groups
in both dorsal and ventral hippocampus as well as in
thalamic PVN (Fig. 1D’–F’). Strikingly, at D30, GFP-
immunoreactive fiber density appeared to be increased in
the hippocampus of TM-treated mice as compared with
vehicle-treated matched controls (Fig. 1D,E). Quantitative
analysis by means of ROD measurements showed a 32%
significant increase in the dorsal hippocampus and 42%
in the ventral part (p  0.01; Fig. 1D’,E’). Conversely, the
extension and density of immunoreactive serotonergic
fibers appeared reduced in the thalamic PVN of D30
TM-treated animals, as confirmed by ROD analysis
(18%, p  0.05; Fig. 1F,F’). To assess whether the
observed alterations in ROD values could be linked to
changes in GFP expression due to a different regulation of
the Tph2 promoter following 5-HT depletion, we mea-
Figure 1. 5-HT depletion in adult mice affects the density of serotonergic fibers that innervate the hippocampus and the thalamic PVN.
A, Experimental timeline of TM treatment in Tph2GFP/fl°x::CMVCreERT mice. B, Representative images of raphe nuclei (top panel) and
hippocampus (bottom panel) highlighting the depletion of serotonin within serotonergic cell bodies and fibers, respectively.
C, Experimental timeline of serotonergic fiber density analysis. D–F, Representative coronal sections immunostained for GFP showing
the distribution of serotonergic fibers in the dorsal hippocampus, ventral hippocampus, and in the thalamic PVN of vehicle- and
TM-treated mice at D30. High-magnification images are shown on the right column of each panel. D’–F’, Quantification of
serotonergic fiber density in the hippocampus and in the thalamic PVN of TM- and vehicle-treated mice. Quantitative analyses were
performed by means of ROD measurements at D14 (n 4 for each treatment), D30 (n 7 for the hippocampus; n 5 for the thalamic
PVN), or D60 (n  8 for the hippocampus; n  6 for the thalamic PVN). Data are presented as percentage increase/decrease of ROD
values of TM-treated mice as compared with vehicle-treated controls  SEM. Wilcoxon singed rank test for paired data were used
as test of significance. p  0.01; p  0.05; n.s., not significant, p  0.05. Scale bar, 350 m (B, top panels; D–F, left panels), 60
m (B, bottom panels), 30 m (D–F, right panels).
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sured the intensity of GFP immunofluorescence within
serotonergic neurons in the raphe nuclei of both TM- and
vehicle-treated mice using the Surface tool of the Imaris
Bitplane software (Fig. 2A). Our analysis revealed no sig-
nificant differences in the intensity of GFP fluorescence
between TM-treated animals and controls (Fig. 2B). We
also used SERT immunostaining as an additional assay to
visualize serotonergic fibers. Results confirmed the pres-
ence of abnormalities in the density of serotonergic inner-
vation within the hippocampus and the thalamic PVN in
line with the data obtained with GFP immunoreactivity
analysis (Fig. 2C).
Analysis of GFP-labeled serotonergic fibers at D60 con-
firmed the altered innervation in animals conditionally
depleted of brain serotonin, showing a serotonergic hy-
perinnervation in both dorsal and ventral hippocampus
(28% and 41%, respectively, p  0.01; Fig. 1D’,E’),
and a reduction of fiber density in thalamic PVN (15%,
p  0.05; Fig. 1F’ ). Moreover, in line with these findings,
TM-treated mice also showed an increased density of
Figure 2. Alterations in the density of serotonergic fibers cannot be ascribed to changes in GFP expression in TM- versus
vehicle-treated mice. A, Representative images showing the levels along the antero-posterior axis where GFP expression was
analyzed (top row) and the 3D masks used to delimit the region in which the intensity of GFP immunosignal was measured (bottom
row). B, Quantification of the intensity of GFP immunosignal in serotonergic neurons of TM- and vehicle-treated mice analyzed 30
days after the end of the treatment (n  7 for each treatment). Analysis was performed using the Surface tool of the Imaris Bitplane
software. C, Representative coronal sections immunostained for SERT showing the distribution of SERT-positive serotonergic fibers
in the dorsal hippocampus, ventral hippocampus, and in the PVN of vehicle- and TM-treated mice analyzed 30 days after the end of
the treatment. Data were analyzed using Wilcoxon signed rank for paired data. n.s., not significant, p  0.05. Scale bar, 400 m (A),
200 m (C, dorsal hippocampus and ventral hippocampus), and 150 m (C, PVN).
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serotonergic fibers in the nucleus accumbens and a re-
duction at the level of the suprachiasmatic nucleus (data
not shown), mirroring what has been reported in Tph2GFP
mutants (Migliarini et al., 2013).
To investigate whether the increased density of seroto-
nergic fibers in the hippocampus could be linked to an
increase in the hippocampal brain-derived neurotrophic
factor (BDNF) regulation that is known to be influenced by
serotonin signaling (Hill et al., 2011; Migliarini et al., 2013;
Homberg et al., 2014; Kronenberg et al., 2016), we analyzed
BDNF mRNA expression levels performing ISH using
35S-radiolabeled antisense BDNF probe on brain coronal
sections of both TM- and vehicle-treated Tph2GFP/fl°x::
CMVCreERT mice at D30. Densitometric analysis of autora-
diographic signal revealed that serotonin depletion did not
impact BDNF mRNA transcriptional regulation (Fig. 3A). In
an additional set of experiments, we used Western blot
analysis to assess the levels of BDNF and its receptor, TrkB.
We found no significant correlation between either BDNF or
TrkB protein level and serotonin depletion during adulthood
(Fig. 3B).
Reestablishing serotonin signaling rescues
serotonergic innervation defects in 5-HT-depleted
mice
We next explored the possibility that the serotonergic
innervation defects observed in TM-treated Tph2GFP/fl°x::
CMVCreERT animals could be reverted by restoring 5-HT
signaling via administration of the serotonin precursor
5-HTP. First, we set up a protocol of 5-HTP administration
to assess the efficiency of 5-HTP treatment in bypassing
the rate-limiting step of serotonin synthesis in Tph2-
deficient animals. To this aim, as in Tph2fl°x line a residual
level of serotonin is maintained (Pelosi et al., 2015), we
used Tph2GFP mutant mice that are devoid of brain sero-
tonin (Migliarini et al., 2013). We found that one-day
5-HTP treatment combining two 20 mg/kg intraperitoneal
injections and 300 mg/kg in drinking water was sufficient
to readily detect serotonergic immunoreactivity in the raphe
region as well as in serotonergic terminals of Tph2GFP mu-
tant mice as compared with saline-treated ones (Fig. 4).
Figure 3. Serotonin depletion in TM-treated mice does not affect
the hippocampal expression of BDNF and TrkB. A, Quantifica-
tion of BDNF mRNA expression in the hippocampus of TM- and
vehicle-treated mice 30 days after the end of the treatment. The
quantification was performed by densitometric analysis of auto-
radiograms resulting from radioactive ISH experiments (n 4 for
each treatment). B, BDNF and TrkB protein expression level
evaluated by Western blot analysis in the hippocampus of TM-
and vehicle-treated mice (n  3 TM-treated, n 4 vehicle-treated
mice) 30 days after the end of the treatment. GADPH and -tubulin
were used to normalize for variations on loading and transfer. Data
are expressed as percentage of control (mean SEM). Student’s t
test was used as test of significance. CA, Ammon’s horn; DG,
dentate gyrus; n.s., not significant, p  0.05.
Figure 4. 5-HTP treatment restores serotonin immunoreactivity in the brain of Tph2GFP mutants. Representative images
highlighting the reestablishment of 5-HT immunoreactivity within serotonergic neurons and fibers of Tph2GFP mutant mice
following 24 h of 5-HTP treatment. Tph2GFP / animals treated with saline were used as controls. Scale bar, 350 m (left
panels) and 60 m (right panels).
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We then tested whether the reestablishment of sero-
tonin signaling could rescue the alterations of seroto-
nergic innervation induced in Tph2GFP/fl°x::CMVCreERT
animals following TM treatment. Tph2GFP/fl°x::CMVCreERT
mice that had received the 5-days TM treatment starting
at P60 to deplete serotonin synthesis were then adminis-
tered at D30 (namely P94) with either saline (i.e. TM/saline)
or 5-HTP (i.e. TM/5-HTP) for the following 30 days (Fig.
5A). Immunohistochemical analyses confirmed in both
dorsal and ventral hippocampus as well as in the thalamic
PVN of Tph2GFP/fl°x::CMVCreERT TM-treated mice that re-
ceived saline the presence of an aberrant serotonergic in-
nervation in line with that described in Figure 1 (Fig. 5B).
Quantitative analysis by RODmeasurements showed a 28%
(p 0.05) and 45% (p 0.05) increase of serotonergic fiber
density in dorsal and ventral hippocampus, and a 13% (p
0.05) decrease in the thalamic PVN as compared with con-
trol animals, respectively (Fig. 5C). Strikingly, GFP-positive
serotonergic fibers in Tph2GFP/fl°x::CMVCreERT TM-treated
animals appeared less packed in both dorsal and ventral
Figure 5. Reestablishing serotonin signaling in Tph2-deficient mice impacts on serotonergic fiber density and compensate alterations
induced by 5-HT depletion. A, Experimental design of 5-HTP administration in TM-treated Tph2GFP/fl°x::CMVCreERT mice (left) and
in Tph2GFP mutant mice (right). B, D, Representative confocal images illustrating the distribution and density of serotonergic fibers in
the hippocampus and in the thalamic PVN. C, E, Quantification by ROD measurements of serotonergic fiber density in the
hippocampus and the thalamic PVN. Data are presented as percentage increase/decrease of ROD values as compared with
vehicle/saline-treated Tph2GFP/fl°x::CMVCreERT controls (n  7 for treatment) or to saline-treated Tph2GFP / mice (n  6 for
treatment)  SEM. Data were analyzed using the Friedman test followed by the Wilcoxon signed rank test and the Bonferroni’s
correction was applied. p  0.001; p  0.01; p  0.05; n.s., not significant, p  0.05. Scale bar, 350 m.
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hippocampus following 30 days of 5-HTP treatment as com-
pared with their saline-treated controls (Fig. 5B). In parallel,
we observed a noticeable increase in the complexity of GFP
fibers in the thalamic PVN of 5-HTP-treated mice as com-
paredwith control animals (Fig. 5B). Consistently, RODmea-
surements highlighted a significant reduction in serotonergic
terminal density of TM/5-HTPmice in the dorsal (13%, p
0.05; Fig. 5C) and ventral (21%, p  0.05; Fig. 5C) hip-
pocampus and a 13% (p  0.05) increase in the thalamic
PVN, as compared with TM/saline controls (Fig. 5C).
In light of these results, we next asked whether the
reestablishment of the serotonergic signaling could have
an impact on the 5-HT innervation of animals that are
life-long depleted in brain 5-HT such as the Tph2GFP
mutant mice. To address this question we submitted 3
months old Tph2GFP mutant mice to our 5-HTP adminis-
tration protocol. Interestingly, following 30 days of 5-HTP
treatment, we observed a reduction of the serotonergic
innervation abnormalities previously described in Tph2GFP
mutant mice (Fig. 5D). Analysis in both dorsal and ventral
hippocampus highlighted a 22% (p  0.05) and 31% (p 
0.05) reduction of fiber density in 5-HTP-treated Tph2GFP
mutants as compared with saline-treated controls (Fig.
5E). In line, reestablishment of serotonin signaling was
sufficient to restore a proper serotonergic innervation in
the thalamic PVN of 5-HTP-treated Tph2GFP / mice as
compared with saline-treated mutant animals (32%, p
0.05; Fig. 5D,E).
Taken together, our data suggest that the serotonergic
system retains a lifelong plasticity allowing it to respond to
transient alterations in brain serotonin homeostasis and
resulting in changes of fiber density in the target areas.
Moreover, results showed that innervation defects ob-
served in 5-HT-depleted mice can be significantly res-
cued by 5-HTP treatment capable to reestablish serotonin
levels.
The depletion/reestablishment of 5-HT signaling in
adult brains affects the sprouting of serotonergic
fibers
Since we demonstrated that 5-HT signaling abrogation/
reestablishment deeply affects the density of 5-HT fibers
innervating the hippocampus, we next wanted to decipher
which morphologic rearrangements in the architecture of
5-HT axons are responsible for the observed alterations in
both Tph2GFP/fl°x::CMVCreERT and Tph2GFP animals. We
hypothesized that both an enlargement in axon diameter,
and/or an active axon sprouting resulting in an increased
complexity of serotonergic innervation could account for
the higher density of 5-HT fibers we have observed, while
both diminished axon diameter and/or branching regres-
sion could explain the fiber density reduction.
To test this hypothesis we analyzed high-magnification
confocal image acquisitions of GFP-labeled 5-HT fibers in
the stratum lacunosum moleculare of the dorsal hip-
pocampus. Imaris software was used to generate 3D
reconstructions of GFP-immunoreactive axons thus al-
lowing an accurate computer-based quantitative and
morphologic fiber analysis (Fig. 6A). Results showed no
significant difference in the diameter of serotonergic fibers
among the different experimental groups in either
Tph2GFP/fl°x::CMVCreERT or Tph2GFP mice (Fig. 6B). Con-
versely, a significant increase of the length of 5-HT fibers
and number of axon branch points was observed be-
tween Tph2GFP/fl°x::CMVCreERT vehicle/saline- and TM-
saline-treated animals resulting in 14% axon branch
point (ABP) versus axon length (AL) ratio (ABP/AL ratio;
p  0.05; Fig. 6B). A similar scenario was observed
comparing Tph2GFP / and / saline-treated mice
(26% ABP/AL ratio; p  0.05; Fig. 6B). Notably, 5-HTP
administration in TM-treated Tph2GFP/fl°x::CMVCreERT
animals promoted a decrease in the total 5-HT fiber length
and the number of branching points, bringing back the
ABP/AL ratio to the level of that observed in control mice
(Fig. 6). In Tph2GFP /mice, 5-HTP treatment promoted
a significant decrease of the ABP/AL ratio, although the
rescue was partial (ABP/AL ratio17% as compared with
Tph2GFP / controls; p  0.01; Fig. 6B). Finally, to
further evaluate the consequences of changes in sero-
tonin homeostasis on serotonergic fiber properties, we
compared the tortuosity of GFP-immunoreactive fibers
between control and experimental animal cohorts (Fig.
6C). We found that the tortuosity index of serotonergic
axons is not affected by serotonin depletion/reestablish-
ment, suggesting that their morphologic properties are
retained independently of serotonin level fluctuations (Fig.
6C).
Overall, 3D reconstruction of serotonergic axon archi-
tecture and morphology quantification demonstrated that
5-HT signaling abrogation/reestablishment in adult mice
can affect proper serotonergic fiber density impinging on
axon branching complexity, but not on morphologic prop-
erties, by either promoting or inhibiting axon sprouting.
Discussion
This study aims to assess whether an appropriate se-
rotonergic neurotransmission during adult life is required
to preserve proper serotonergic circuitry. Here, we show
that depletion of brain serotonin in adult mice produces
severe abnormalities in serotonergic fiber density with a
region-specific effect and that these alterations can be
reversed with chronic 5-HTP administration that restores
5-HT signaling.
To efficiently address the consequences of 5-HT deple-
tion in adult brains, we analyzed the density of serotoner-
gic fibers focusing on the hippocampus and the thalamic
PVN that displayed diametrically opposite phenotypes in
the Tph2 KO mouse model as a consequence of brain
5-HT depletion (Migliarini et al., 2013). Remarkably, we
report that 5-HT synthesis abrogation in adult Tph2 cKO
mice results, after four weeks, in the alteration of seroto-
nergic fiber density as observed by the analysis of both
SERT and GFP immunoreactivity. Such a phenotype mim-
ics the abnormalities observed in mice with a life-long
depletion of brain serotonin. We also show that the
changes of fiber density induced by serotonin depletion
can be rescued by restoring brain 5-HT signaling in Tph2
cKO as well as in Tph2 KO animals. These results corrob-
orate the hypothesis that serotonin itself acts as a mod-
ulator of serotonergic fiber density, as already proposed
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to explain the phenotype of Tph2GFP mutants (Migliarini
et al., 2013). Serotonin is known to exert a trophic auto-
crine activity during development and at postnatal stages
when 5-HT axons sprout to innervate their targets (Lidov
and Molliver, 1982). Our findings reveal that the impact of
serotonin on serotonergic axon sprouting is not restricted
to critical periods during the course of neurodevelopment,
but it is maintained in adulthood. Altogether, the ability of
serotonin to act as a regulator of serotonergic axon
sprouting and the evidence that this feature is retained
during adult stages of life reveal an unexpectedly high
plasticity of adult serotonergic circuitry, putting forward
its responsiveness to fluctuations in brain serotonin con-
tent.
Growing evidence for a structural plasticity of axons in
the adult brain, defined as the ability to rearrange and
sprout under specific circumstances, such as spontane-
ous or experience-dependent activity, has been reported
in different neuronal types (De Paola et al., 2006; Stettler
et al., 2006; Gogolla et al., 2007; Butz et al., 2009; Yama-
hachi et al., 2009; Barnes and Finnerty, 2010; Marik et al.,
2010, 2013, 2014). To date, the ability of adult serotoner-
gic axons to undergo active sprouting has been described
solely in response to physical lesions of brain or spinal
cord (Zhou and Azmitia, 1984; Azmitia and Whitaker-
Azmitia, 1991; Zhou et al., 1995; Camand et al., 2004;
Hawthorne et al., 2011; Jin et al., 2016). However, tissue
lesion represents a nonphysiologic condition in which the
environment is enriched with a large repertoire of mole-
cules, which possess the ability to influence the behavior
of local 5-HT fibers (Dusart et al., 1999; Camand et al.,
2004; Hawthorne et al., 2011). Our findings go beyond this
view showing that axonal structural plasticity represents
an intrinsic property of serotonergic fibers independently
of tissue damage and that plasticity of serotonergic ter-
minals can be modulated by changes in serotonergic
homeostasis. On the other hand, an intriguing question is
how the manipulation of brain serotonin levels may trigger
bidirectional dynamic structural rearrangements of sero-
tonergic fibers, such as axon sprouting or reduction of
Figure 6. Computer-based mapping of serotonergic fibers and quantitative analysis of axon morphology. A, Representative
high-magnification confocal acquisition in oblique view of GFP-immunoreactive serotonergic fibers (green) and computer-based 3D
reconstructions (red). B, Graphs showing the quantification of the axon mean diameter and the ABP/AL ratio in Tph2GFP/fl°x::
CMVCreERT (n  5 for treatment) and Tph2GFP (n  5 for treatment). Data were normalized to vehicle/saline-treated Tph2GFP/fl°x::
CMVCreERT controls and saline-injected Tph2GFP / controls, respectively, and presented as mean percentage increase of controls
 SEM. C, Graphs showing the average tortuosity index (defined as the length of the axon divided by the Euclidean distance between
the ends or branch points) of serotonergic fibers under the different experimental conditions. Data are presented as the mean SEM.
Analysis of significance was performed using the Friedman test, followed by the Wilcoxon signed rank test. p 0.001; p 0.01;
p  0.05; n.s., not significant, p  0.05. Scale bar, 4 m.
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axon arbor complexity. A tempting hypothesis is that, as
reported for other neuronal types (De Paola et al., 2006;
Stettler et al., 2006; Nishiyama et al., 2007), serotonergic
fibers are highly dynamic in physiologic conditions under-
going continuous small rearrangements, such as branch
elongation and retraction. When drastic changes in 5-HT
brain levels occur, such as those induced by TM treat-
ment in conditional Tph2 KO or by chronic 5-HTP admin-
istration, the dynamic equilibrium of 5-HT axons is
unbalanced toward either elongation or retraction, result-
ing in fiber sprouting or reduction of axon arbor complex-
ity, respectively.
Another aspect that remains elusive is how serotonin
depletion/reestablishment can produce diametrically op-
posite phenotypes of serotonergic innervation to specific
structures, such as the hippocampus and the thalamic
PVN. On one side, we can hypothesize that an intrinsic
heterogeneity in the targets might be implied in the dis-
tinct response of serotonergic fibers to fluctuations of
5-HT levels. Indeed, as the distribution of serotonergic
receptors and their downstream effectors is highly vari-
able in the rostral brain (Wirth et al., 2016), the response to
serotonin deregulation is the outcome of the integration of
signals encoded by the specific combination of receptors
expressed in each target region. On the other side, it is
likely that 5-HT neurons projecting to the hippocampus
and the thalamic PVN possess intrinsic differences that
might contribute to the opposite effect elicited by sero-
tonin depletion/reestablishment. Indeed, although seroto-
nergic fibers innervating the hippocampus and the
thalamic PVN manly arise from neurons of same raphe
nucleus, namely the median raphe nucleus (Muzerelle
et al., 2016), there is now clear evidence that a marked
intrinsic heterogeneity exists even among serotonergic
neurons belonging to the same anatomic domain. Indeed,
distinct subtypes of 5-HT neurons that differ in their de-
velopmental origin (Jensen et al., 2008), molecular profile
(Okaty et al., 2015) as well as in their electrophysiological
properties and cotransmitter repertoire (Gaspar and
Lillesaar, 2012; Fernandez et al., 2015) have been identi-
fied, suggesting the possibility that specific subtypes of
serotonergic neurons may be specialized to mediate dif-
ferent biological functions. Moreover, serotonergic neu-
rons that project to distinct forebrain regions largely
belong to different serotonergic subpopulations (Fernan-
dez et al., 2015). Based on this evidence, our observation
of an opposite phenotype after serotonin depletion/rees-
tablishment suggests that serotonergic fibers innervating
the hippocampus and the thalamic PVN may arise form
distinct subpopulation of median raphe 5-HT neurons.
Overall, it is likely that the specific combination of sero-
tonergic receptors in target areas along with the intrinsic
properties of 5-HT neurons projecting to the same target
contribute to the establishment of a regional specificity in
the way changes in serotonin levels drive 5-HT fiber rear-
rangements.
It has been reported that modulating 5-HT signaling by
administration of either fluoxetine or agonists of 5-HT
receptors facilitates the recovery of locomotion after a
spinal cord injury (SCI) in rodents (Courtine et al., 2009;
Musienko et al., 2011; Scali et al., 2013). However, the
precise mechanisms underlying this response are still
waiting to be elucidated. In this respect, an intriguing
question to address would be whether a potential role in
post-SCI recovery, besides the reported action of sero-
tonin itself, could be ascribed to serotonergic axons. In
fact, because of their intrinsic capability to regrow follow-
ing injury, serotonergic fibers may act as forerunners
facilitating the navigation and sprouting of other types of
axons through the edge of the lesion. Thus, in the future,
it will be interesting to evaluate whether (1) the capability
of serotonergic axons to actively sprout in response to
injury and (2) the post-SCI recovery triggered by modula-
tion of 5-HT signaling are retained in the absence of
serotonin, such as in our Tph2 cKO.
As BDNF expression has been reported to be influ-
enced by serotonin signaling (Hill et al., 2011; Migliarini
et al., 2013; Homberg et al., 2014; Kronenberg et al.,
2016), we wondered whether this neurotrophin could act
as a potential molecular mediator in the establishment of
the observed alterations in 5-HT fiber density. However,
we failed to detect any significant alteration in the hip-
pocampal level of BDNF in our Tph2 cKO mice, suggest-
ing that other factors are likely involved in the response of
5-HT depletion during adult stages of life. Noteworthy, the
increase of hippocampal BDNF in Tph2 mutant mice is
detectable as early as P14, indicating that early phases of
postnatal development represent a temporal window in
which serotonin depletion can affect BDNF expression.
Conversely, it is likely that the ability to influence BDNF
hippocampal levels is lost in adult brains. Accordingly, the
existence of specific temporal windows during postnatal
development in which 5-HT signaling produces specific
effects that cannot be replicated later in life has been
extensively demonstrated (Gross et al., 2002; Ansorge
et al., 2004, 2008; Suri et al., 2015).
On the whole, we have shown that drastic changes in
brain 5-HT content during adulthood affect, in a reversible
manner, serotonergic fiber density and complexity, thus
providing the evidence of a direct link between 5-HT
homeostasis and structural plasticity of serotonergic ax-
ons in the adult brain. In this view, it should be taken into
account that also subtle changes of brain 5-HT homeostasis
induced by genetic factors, pharmacological treatments, as
well as environmental conditions, might impinge on seroto-
nergic terminal sprouting, thus affecting the proper 5-HT
circuitry and, potentially, interfering with its functioning.
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